Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/29314
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2022-11-02T06:10:14Z-
dc.date.available2022-11-02T06:10:14Z-
dc.date.issued2007-
dc.identifier.citationGüllülü, M. vd. (2007). "Paraoxonase activity in glomerulonephritic patients". Renal Failure, 29(4), 433-439.en_US
dc.identifier.issn1525-6049-
dc.identifier.issn0886-022X-
dc.identifier.urihttps://doi.org/10.1080/08860220701278216-
dc.identifier.urihttps://www.tandfonline.com/doi/full/10.1080/08860220701278216-
dc.identifier.urihttp://hdl.handle.net/11452/29314-
dc.description.abstractBackground. Cardiovascular disease is the most common cause of morbidity and mortality in patients with chronic renal failure. Glomerulonephritic patients have an increased risk for cardiovascular disease, but its etiology is unclear. It is known that an increase in oxidizability of apolipoprotein B-containing lipoproteins has a key role in the initiation of atherosclerosis, and paraoxonase enzyme activity particularly has a preventive role against atherosclerosis. The aim of the present study was to evaluate the oxidizability of apolipoprotein B-containing lipoproteins, serum, and urinary paraoxonase/arylesterase activities in g] omerulonephritis patients who had normal lipid parameters and creatinine levels. Methods. Thirty-two patients with glomerulonephritis and 22 healthy controls were included in this study. A total of 32 patients (including nine with membranous GN, eight with immunoglobulin A nephropathy, eight with mesangial prolifferative GN, five with focal-segmental glomerulosclerosis, one with diffuse proliferative GN, and one with minimal chance disease having biopsy proven GN) were enrolled into the study. We compared serum and urinary paraoxonase, arylesterase, serum lipids, urea, creatinine, hemoglobin, total protein and albumin values between groups. Results. Serum urea, creatinine, total protein, albumin, uric acid, hemoglobin, and lipid parameters were similar in the glomerulonephritis and control groups (p > 0.05). PON1 activity was significantly lower in GN group nan controls, but there was no statistically significant difference on arylesterase activity between groups. Oxidizability of apolipoprotein B-containing lipoproteins was significantly higher in GN group than controls. Conclusion. Our study shows that the findings of normal serum levels of creatinine, lipids, and protieins increased the oxidizability of apolipoprotein B-containing lipo-proteins, and any decrease in PON1 activity in patients diagnosed with GN should be considered important. Hence, the immediate commencement of preventive as well as curative treatment in other to avoid the risk of cardiovascular and renal problems would be a correct approach.en_US
dc.language.isoenen_US
dc.publisherTaylor & Francistr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectGlomerulonephritisen_US
dc.subjectLow-density-lipoproteinen_US
dc.subjectUrology & nephrologyen_US
dc.subjectLipiden_US
dc.subjectOxidationen_US
dc.subjectParaoxonaseen_US
dc.subjectUrinary paraoxonaseen_US
dc.subjectUremic patientsen_US
dc.subjectOxidized ldlen_US
dc.subjectArylesteraseen_US
dc.subjectDecreaseen_US
dc.subjectDiseaseen_US
dc.subjectCellsen_US
dc.subject.meshApolipoproteins Ben_US
dc.subject.meshAdulten_US
dc.subject.meshHumansen_US
dc.subject.meshAryldialkylphosphataseen_US
dc.subject.meshCarboxylic ester hydrolasesen_US
dc.subject.meshCreatinineen_US
dc.subject.meshFemaleen_US
dc.subject.meshGlomerulonephritisen_US
dc.subject.meshMaleen_US
dc.subject.meshMalondialdehydeen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshOxidation-reductionen_US
dc.subject.meshUreaen_US
dc.titleParaoxonase activity in glomerulonephritic patientsen_US
dc.typeArticleen_US
dc.identifier.wos000246966300007tr_TR
dc.identifier.scopus2-s2.0-34248512653tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Biyokimya Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Dahiliye Anabilim Dalı.tr_TR
dc.relation.bap2004/47tr_TR
dc.contributor.orcid0000-0002-0710-0923tr_TR
dc.identifier.startpage433tr_TR
dc.identifier.endpage439tr_TR
dc.identifier.volume29tr_TR
dc.identifier.issue4tr_TR
dc.relation.journalRenal Failureen_US
dc.contributor.buuauthorGüllülü, Mustafa-
dc.contributor.buuauthorKahvecioğlu, Serdar-
dc.contributor.buuauthorDirican, Melahat-
dc.contributor.buuauthorAkdağ, İbrahim-
dc.contributor.buuauthorOcak, Nihal-
dc.contributor.buuauthorDemircan, Celalettin-
dc.contributor.buuauthorDilek, Kamil-
dc.contributor.buuauthorErsoy, Alpaslan-
dc.contributor.buuauthorYavuz, Mahmut-
dc.contributor.buuauthorYurtkuran, Mustafa-
dc.contributor.researcheridAAG-6985-2021tr_TR
dc.contributor.researcheridAAH-5054-2021tr_TR
dc.identifier.pubmed17497465tr_TR
dc.subject.wosUrology & nephrologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubMeden_US
dc.wos.quartileQ4en_US
dc.contributor.scopusid6602684544tr_TR
dc.contributor.scopusid55956719500tr_TR
dc.contributor.scopusid6601919847tr_TR
dc.contributor.scopusid8342488100tr_TR
dc.contributor.scopusid23989248600tr_TR
dc.contributor.scopusid6507741676tr_TR
dc.contributor.scopusid56005080200tr_TR
dc.contributor.scopusid35612977100tr_TR
dc.contributor.scopusid7006244754tr_TR
dc.contributor.scopusid7003389525tr_TR
dc.subject.scopusAryldialkylphosphatase; Arylesterase; Human PON1 Proteinen_US
dc.subject.emtreeUreaen_US
dc.subject.emtreeAlbuminen_US
dc.subject.emtreeApolipoprotein Ben_US
dc.subject.emtreeAryldialkylphosphataseen_US
dc.subject.emtreeArylesteraseen_US
dc.subject.emtreeCreatinineen_US
dc.subject.emtreeHemoglobinen_US
dc.subject.emtreeLipiden_US
dc.subject.emtreeUric aciden_US
dc.subject.emtreeLipoprotein blood levelen_US
dc.subject.emtreeClinical articleen_US
dc.subject.emtreeHemoglobin blood levelen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBiopsyen_US
dc.subject.emtreeCardiovascular risken_US
dc.subject.emtreeComparative studyen_US
dc.subject.emtreeEnzyme activityen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeCreatinine blood levelen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeEnzyme blood levelen_US
dc.subject.emtreeGlomerulonephritisen_US
dc.subject.emtreeStatistical significanceen_US
dc.subject.emtreeGlomerulosclerosisen_US
dc.subject.emtreeImmunoglobulin A nephropathyen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeKidney diseaseen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeProtein blood levelen_US
dc.subject.emtreeUrea blood levelen_US
Appears in Collections:PubMed
Scopus
Web of Science

Files in This Item:
File Description SizeFormat 
Güllülü_vd_2007.pdf278.08 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons